(0) items in cart / view cart / checkout  
More
 
  Chemicals
  Company Profiles
  Country Analyses
  Energy and Utilities
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > In Vitro Diagnostics > Strategic Planning >  Leading Diagnostics Companies Strategic Directions

Leading Diagnostics Companies Strategic Directions
 

For each company, the report provides insightful strategic assessments, including:
  • Business, new product development, and marketing strategies.
  • Anticipated acquisitions, joint ventures, and divestitures.
The companies analyzed in the report: Abbott, Bayer Diabetes, Beckman Coulter, Becton Dickinson, bioMerieux, Bio-Rad, J&J, Roche, Siemens, and Sysmex.

Contains 65 pages



To order sections of this report, contact Client Services


     
   
Local PDF: $2450.00
Other Formats: Global PDF, DataPack
   
   
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X